1-N-BOC 3-(4-AMINOPIPERIDIN-1-YL) PYRROLIDINE, 95.0%, 1g

Methyl 4-amino-2-bromobenzoate, 95.0%, 25g

Ethylène Glycol, min 99%, pour la synthèse, 5L, emballage plastique.

2',5-Dichloro-2-hydroxybenzophenone>98.0%(GC)1g

2,5-Dihydroxybenzoic Acid Butylamine Salt [Matrix for MALDI-TOF/MS]>98.0%(HPLC)(T)1g

4-Pyridinecarboxamide, 2-(cyclobutylamino)-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-, 98%, 5mg

3,4-Bis(4-methoxybenzoyl)-1,2,5-oxadiazole 2-oxide, 97%, 2g

Tubes à centrifuger coniques, sans bord, 50 ml, Stérile, 300 Pièce(s)

4-(3-Bromopropyl)morpholin-3-one, 95%, 1g

1,4,5,8-Naphthalenetetracarboxylic dianhydride, 95.0%, 50g

3-(PYRIDIN-4-YLOXY)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 95.0%, 100mg

4-Bromo-2-(methylsulfonyl)pyrimidine, 95.0%, 250mg

tert-Butyl 3-(hydroxymethyl)-2-oxa-7-azaspiro[4.5]decane-7-carboxylate, 95%, 2g